Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Ascendis Pharma A/S
ASND
$16.8B
| $8.43M | ﹤0.01% |
56,448
-1,338
| -2% | -$181K |
|
2477
Greenlight Captial
GLRE
$501M
| $8.43M | ﹤0.01% |
617,239
-8,587
| -1% | -$114K |
|
2478
ACNB Corp
ACNB
$646M
| $8.36M | ﹤0.01% |
191,437
+2,026
| +1% | +$80.4K |
|
|
LGTY
2479
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $8.36M | ﹤0.01% |
746,715
-84,409
| -10% | -$877K |
|
2480
Nu Skin
NUS
$250M
| $8.33M | ﹤0.01% |
1,130,487
+11,838
| +1% | +$111K |
|
2481
Aquestive Therapeutics
AQST
$538M
| $8.31M | ﹤0.01% |
1,667,515
+90,543
| +6% | +$352K |
|
|
BBUC
2482
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.9B
| $8.29M | ﹤0.01% |
326,983
+1,108
| +0.3% | +$24.5K |
|
|
CNSL
2483
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $8.28M | ﹤0.01% |
1,784,789
-66,260
| -4% | -$301K |
|
2484
Zumiez
ZUMZ
$330M
| $8.28M | ﹤0.01% |
388,589
+1,195
| +0.3% | +$28.6K |
|
2485
Vishay Precision Group
VPG
$864M
| $8.28M | ﹤0.01% |
319,486
+11,391
| +4% | +$324K |
|
|
HDSN
2486
Hudson Technologies
HDSN
$240M
| $8.27M | ﹤0.01% |
990,856
+10,707
| +1% | +$88.6K |
|
2487
Preformed Line Products
PLPC
$2.26B
| $8.24M | ﹤0.01% |
64,323
-1,677
| -3% | -$204K |
|
2488
Aehr Test Systems
AEHR
$3.46B
| $8.21M | ﹤0.01% |
639,149
+18,521
| +3% | +$268K |
|
|
GPGI
2489
GPGI Inc
GPGI
$4.16B
| $8.21M | ﹤0.01% |
705,238
+179,195
| +34% | +$1.52M |
|
2490
Tactile Systems Technology
TCMD
$657M
| $8.16M | ﹤0.01% |
558,667
+8,422
| +2% | +$109K |
|
2491
El Pollo Loco
LOCO
$463M
| $8.15M | ﹤0.01% |
594,576
-27,716
| -4% | -$347K |
|
|
SLRN
2492
DELISTED
ACELYRIN
SLRN
| $8.14M | ﹤0.01% |
1,651,614
+388,631
| +31% | +$2.01M |
|
2493
Luxfer Holdings
LXFR
$457M
| $8.13M | ﹤0.01% |
627,817
+15,030
| +2% | +$175K |
|
|
USAP
2494
DELISTED
Universal Stainless & Alloy
USAP
| $8.07M | ﹤0.01% |
208,888
+2,646
| +1% | +$94.3K |
|
2495
Costamare
CMRE
$1.74B
| $8.07M | ﹤0.01% |
513,382
-2,523
| -0.5% | -$36.4K |
|
2496
RBB Bancorp
RBB
$450M
| $8.05M | ﹤0.01% |
349,460
-4,693
| -1% | -$102K |
|
2497
Anika Therapeutics
ANIK
$277M
| $8.03M | ﹤0.01% |
324,964
-16,104
| -5% | -$418K |
|
|
LENZ
2498
LENZ Therapeutics
LENZ
$168M
| $8.03M | ﹤0.01% |
338,024
-22,096
| -6% | -$490K |
|
2499
Pulse Biosciences
PLSE
$2.96B
| $8.02M | ﹤0.01% |
457,165
+33,200
| +8% | +$566K |
|
2500
Southern California Bancorp
BCAL
$687M
| $8.02M | ﹤0.01% |
542,147
+278,874
| +106% | +$4.06M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.